286 related articles for article (PubMed ID: 23113674)
1. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.
Okyay GU; Inal S; Oneç K; Er RE; Paşaoğlu O; Paşaoğlu H; Derici U; Erten Y
Ren Fail; 2013; 35(1):29-36. PubMed ID: 23113674
[TBL] [Abstract][Full Text] [Related]
2. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease.
Kocyigit I; Eroglu E; Unal A; Sipahioglu MH; Tokgoz B; Oymak O; Utas C
J Nephrol; 2013; 26(2):358-65. PubMed ID: 22573523
[TBL] [Abstract][Full Text] [Related]
3. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
4. Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
[TBL] [Abstract][Full Text] [Related]
5. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
6. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
7. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease.
Dounousi E; Koliousi E; Papagianni A; Ioannou K; Zikou X; Katopodis K; Kelesidis A; Tsakiris D; Siamopoulos KC
Am J Nephrol; 2012; 36(6):531-6. PubMed ID: 23258075
[TBL] [Abstract][Full Text] [Related]
8. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
9. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
13. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
14. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.
Turkmen K; Erdur FM; Ozcicek F; Ozcicek A; Akbas EM; Ozbicer A; Demirtas L; Turk S; Tonbul HZ
Hemodial Int; 2013 Jul; 17(3):391-6. PubMed ID: 23522328
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.
Recio-Mayoral A; Banerjee D; Streather C; Kaski JC
Atherosclerosis; 2011 Jun; 216(2):446-51. PubMed ID: 21414625
[TBL] [Abstract][Full Text] [Related]
16. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
[TBL] [Abstract][Full Text] [Related]
17. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
18. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
19. [Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].
González AI; Brites F; Elbert A; Gómez-Rosso L; Berg G; Wikinski R; Schreier L
Medicina (B Aires); 2010; 70(6):508-12. PubMed ID: 21163737
[TBL] [Abstract][Full Text] [Related]
20. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]